Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor

Assignee

• Unity Biotechnology
• Mayo Foundation
• Buck Institute For Research On Aging

Inventors

• Remi-Martin Laberge (24 patents)
• Judith Campisi (30 patents)
• Marco Demaria (20 patents)
• Bennett G. Childs (9 patents)
• Jan M.A. van Deursen (17 patents)
• Nathaniel David (44 patents)
• Alain P. Vasserot (96 patents)

View full patent text on Google Patents →